Cell2B is a biotechnology company dedicated to the development of a new line of healthcare therapies to prevent and treat organ rejection in patients undergoing organ or tissue transplants. Cell-based therapy has the potential to impact the life of more than 175,000 patients per year in Europe. Cell2B focuses on the development and processing of cell-based therapies for treating patients and improving their quality of life. Cell2B, incorporated in 2011, also focuses on research and development (R&D) of new cellular therapies for clinical use and offers complementary activities to R&D in the cell therapy space. R&D in cellular therapy is crucial in Cell2B’s vision, it enables to improve therapeutic solutions for the patients.
| Website | http://www.cell2b.com |
| Revenue | $5 million |
| Employees | View employees |
| Founded | 2011 |
| Phone | +351 231 410 906 |
| Technologies |
JavaScript
,
HTML
,
PHP
+3 more
(view full list)
|
| Industry | Biotechnology, Manufacturing General, Manufacturing, Science and Engineering |
| Competitors | Google, Verizon Wireless, Cricket Wireless, MetroPCS, UScellular, T-Mobile, Virgin Mobile USA, AT&T, Boost Mobile Select Retailer, Mobile City +40 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541711 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Cell2B employee's phone or email?
Cell2B Questions
The Cell2B annual revenue was $5 million in 2026.
The NAICS codes for Cell2B are [54, 541711, 54171, 541, 5417].
The SIC codes for Cell2B are [80, 283, 28].
